Clinical Trial Update: Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating eplerenone for elderly patients with hypertension and early-stage chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Inspra (eplerenone)

Snippet

Sponsor: Jichi Medical University | Conditions: Hypertension, Chronic Kidney Disease. | Phase 4 | Status: WITHDRAWN